More specifically, the comparison of UBE2S, UBE2C, and Numb mRNA expression across nine independent analyses demonstrated that UBE2S and UBE2C were markedly elevated and Numb was significantly reduced in breast cancer (Figure 3A). The gene discussed is NUMB; the disease is breast carcinoma.